Purest CBD

We have the World’s PUREST CBD oil and we are super excited to make it available to everyone.

Our Full Spectrum CBD oils are 100% organic, NON-GMO, there are NO artificial or synthetic ingredients and DEFINITELY NO fillers. Our oils are made in the USA on farms in Kentucky & Colorado and ALL our plants are hand-picked and harvested for the BEST QUALITY and PURENESS. We offer 3 different flavors: Peppermint (our favorite), Cinnamon and Natural (No flavor).

You will only find 2 ingredients in our oils plus 1 if you choose to go with a flavor. So, there isn’t a ton of other things that dilute the quality of our CBD.

We are so confident in our product that we give a 60 DAY EMPTY BOTTLE MONEY BACK GUARANTEE !!!

WAIT there’s more… We also have CBD topical creams, hemp infused coffee, keto creamers, and CBD PET products!!!



These 3 Small Cap CBD Stocks Could Benefit with Passage of the 2018 Farm Bill

These three small cap CBD stocks could benefit nicely with the Passage of the 2018 Farm Bill. It should lead to a Flurry of M&A Activity in the #CBD Sector including this recent development, Canopy Growth Corp. CGC said Monday it has been granted a license to process and produce hemp in New York state. The company said it is planning to invest $100 million to $150 million in a New York base, capable of producing tons of hemp extract.

Established Players such as: American Premium Water, Corp. (OTC: HIPH); EnviroTechnologies International, Inc. (OTC: ETII and Medifirst Solutions (OTC: MFST)

American Premium Water, Corp.

American Premium Water, Corp. (OTC: HIPH) the marketer and distributor of the first hydro-nano #CBD infused beverage on the market, is another company in the CBD space that has been linked to a larger, established beverage company. It was reported that American Premium Water’s (OTC:HIPH) CEO had met with National Beverage Corporation (OTC:FIZZ), the manufacturer and distributer of various beverage brands, including the premium carbonated brand LaCroix, to discuss a potential partnership or minority investment. This would make a lot of sense for National Beverage, whom has also been besieged by its own scandal involving arsenic with its signature brand LaCroix. American Premium Water HIPH announced that it acquired proprietary #CBD hydro-nano formulations, which National Beverage could utilize for its line of beverages, including LaCroix. An entry into the burgeoning #CBD space for HIPH would re-invigorate the company, and they would be able to scale very quickly their wide distribution network a #CBD infused beverage where there is a lot of thirst for product. Breaking news on HIPH: American Premium Water Corp. announces Financing Arrangement at a .40 Valuation. HIPH is currently trading at .08

EnviroTechnologies International, Inc.

EnviroTechnologies International, Inc. (OTC: ETII) is in a good position to take advantage of the burgeoning Hemp/CBD Pet industry. ETII’s products are poised for greater distribution now that the Farm Bill has passed. ETII also markets and sells green, environmentally safe products and solutions to the Oil and Gas and the Food and Agriculture industries as well as consumer products, using the Company’s unique technologies, which include proprietary machines that create electrolyzed oxidative water. #CBD Health Co. launched a sister fitness and media company that will market fitness hemp-based products and health films, Phytolife Fitness and Media will release weekly videos on CBD health, meal preparation, and normal incorporation of our products into their diets, daily regimen and lifestyle. ETII also develops and markets proprietary, synergistic products for the oil and gas and agriculture industries as well as wellness products. The company’s products are safe, natural, and non-toxic and “green” products for industries that often show little concern for the environment but are now feeling the social and governmental need to go “green.” The company’s completely green and natural products are proprietary, unique and highly effective innovations to its target markets including #CBD. OTC:ETII has been climbing up the charts recently. Please visit: www.cbdhealthstock.com for more information on ETII

Medifirst Solutions

Medifirst Solutions (OTC: MFST) is an enticing Small Cap company with 3 amazing businesses: the new CBD business, FDA approved Laser and specialty pharmacy drugs. MFST has a Very low Stock structure. Medifirst MFST has completed an agreement with Dr. Gupta Pharma LLC to distribute a line of premium CBD oils. As the President of the American Pain Association, Dr. Gupta believes that #CBD, used under the guidance of a physician, can play a significant role in reducing pain and helping to curb the opioid epidemic. Medifirst Solutions (OTC: MFST) established in 2011, has an FDA cleared revolutionary and innovative laser technology and in a recently announced new division, offers specialty pharmacy drug and consulting services. MFST just announced huge news. Concierge Concepts Rx (CCRx), a division of Medifirst Solutions, has signed an exclusive three-year Specialty Pharmacy Consulting Agreement with a New Jersey based, billion-dollar company that owns 153 convenience stores including pharmacy services. They have 4000 employees in New Jersey and New York locations. There is no hotter sector in the pharmaceutical industry than specially drugs. Industry analysts project the total pharmaceutical industry to exceed $483 billion in 2020. Please visit: www.cbdpubco.com for more information on MFST





Canadian Cannabis Cultivators To Pick Up The Slack..

Canadian based cannabis firms are set to ramp up supply after the country is reportedly experiencing a shortage.
After the recent legalization of recreational cannabis in Canada, it has been reported that dispensaries were experiencing a shortage from the huge influx of consumers looking to get their hands on some legal recreational marijuana.
Local authorities were called to a number of dispensaries struggling to handle the long queues and frustrated consumers unable to buy cannabis.
Bill Blair, former Toronto police chief, who has been at the forefront of the government’s legalization program, told public broadcaster CBC the country was unprepared for the huge surge in demand.
“We had anticipated, you know, certain strains might run out and there would be a bit of a run on supply,” he said, “But, you know, they have got a good infrastructure in place and I’m confident it will work.”
On October 17th, Canada became only the second country in the world to fully legalize recreational marijuana use, as part of a somewhat controversial experiment in their drug policy. Under the new law Canadian citizens can legally carry up to 30 grams of cannabis in public and each household will be able to grow up to four plants.
According to a spokesperson for Cronos Group “With the recent legalization of recreational marijuana, we had increased our output considerably” he said, “We did not expect the demand to be so large, however, we now know we need to increase our supply further, to make sure we can keep up with the increased demand.”
Medical marijuana has been legal in Canada since 2001, and the government has spent over two years working to expand that to include recreational usage. Based on the results of their survey 5.4 million Canadians will buy cannabis from legal dispensaries in 2018, that is over 15 percent of the population. Around 4.9 million already medicate.
Supply and demand economics dictate that this shortage in the marijuana supply will lead to an uptick in the price, which will no doubt have a knock on effect with the revenues generated from the industry. This will likely have a positive effect on the share price of one of our top stock picks for this quarter Cronos Group (CRON) and as a result, we have issued a strong buy recommendation for our clients, here at Asia Associates.

Chief Analyst, Dennis Chu – Asia Associates

Pot Stocks Can’t Be Ignored, an Editorial from Barron’s

A recent Barron’s article by Steve Garmhausen, titled ‘Pot Stocks Can’t Be Ignored’, puts a spotlight on the strong performance of marijuana stocks through the first three-quarters of 2018. As the article notes,“Marijuana stocks have been an investor darling this year, with even hedge fund billionaire Leon Cooperman betting his own money in the sector.” The most recent buying frenzy in the space came on the heels of a late-August report that alcoholic beverage giant Diageo (NYSE: DEO) was in talks to invest in or partner with at least three Canadian cannabis companies. Tilray (NASDAQ: TLRY), one of the largest and most sophisticated producers of premium medical cannabis in the world, saw its shares skyrocket from $17 at its July IPO to a high of more than $62 earlier this week. Likewise, Cronos (NASDAQ: CRON), which commenced trading on the Nasdaq in February, rose from a mid-August low of $5.65 to a 52-week high of $12.89 in the wake of the Diageo news. “This is like bitcoin levels, the kind of move Tilray is making,” cannabis investor Jason Spatafora told MarketWatch. “The market is completely irrational.”

Marijuana stocks have been an investor darling this year, with even hedge fund billionaire Leon Cooperman betting his own money in the sector. Their big gains, including a spike in the past several days, will force advisors to take a position—whether it’s ushering their clients into the party, or just saying no.

A buying frenzy in pot-related companies touched off last week after a report that Diageo, the company behind Smirnoff and Johnnie Walker, was in talks to invest in or partner with at least three Canadian pot companies, MarketWatch notes.

That lifted firms like Tilray [TLRY] and Cronos Group [CRON]. Tilray sparked another leg up Wednesday by beating quarterly earning expectations. Since its July IPO, Tilray has shot from $17 to $61 per share. Cronos started trading on the Nasdaq in February and has since risen from $8.24 to $12.74 a share.

Is some irrational exuberance at work? Perhaps. “This is like bitcoin levels, the kind of move Tilray is making,” cannabis investor Jason Spatafora told MarketWatch. “The market is completely irrational. [Tilray’s] market capitalization is over $4.5 billion. That’s insane. They don’t have as much cash as [big rivals] Canopy or Aurora. It shouldn’t trade at half that valuation.”

For his part, Cooperman holds a position in Green Thumb Industries [GTBIF], a publicly-traded marijuana cultivator and dispensary operator, according to Business Insider.

For a deep dive into the business of marijuana, check out this March cover story from my Barron’s colleague Bill Alpert.

Steve Garmhausen

About Barron’s

Barron’s is America’s premier financial magazine. It provides in-depth analysis and commentary on the markets, updated every business day online. For more information, visit www.Barrons.com

Cannabis Strategic Ventures, Inc. (NUGS) Does Deal for Clean Cannabis as New Regulations Take Effect

(Cannabis News Wire/Network News Wire) —

  • New regulations mandate cleaner, safer cannabis
  • Cannabis concentrate extraction deal with CGMP-compliant facility
  • Launchof Pure Organix with vape pen cartridges
  • Appointment of CPG-experienced board member

The deal that Cannabis Strategic Ventures, Inc. (OTC: NUGS) recently struck with Sunniva Inc. comes at a crucial time in the California cannabis industry. On July 1, new, stricter regulations came into force that caused quite a kerfuffle; retailers were forced to sell off non-compliant products in what has been labelled a “fire sale” of cannabis. As the industry develops, California state authorities appear to be building a robust regulatory regime, which will put a premium on quality products like those marketed by NUGS. The company plans to introduce a line of branded cannabis extract products under the name ‘Pure Organix’.

Regulation of cannabis in California has had a long history. The state was the first to legalize cannabis for medical purposes after it passed the Compassionate Use Act in 1996, but a lot has happened since then. In June 2017, an attempt to consolidate and streamline regulations was made with the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA). Now, under MAUCRSA, there are three state agencies responsible for regulating and licensing cannabis operators: the California Department of Food and Agriculture (CDFA), which regulates cultivators, processors, and nurseries; the California Department of Public Health’s (CDPH) Manufactured Cannabis Safety Branch, which regulates cannabis manufacturers; and the Bureau of Cannabis Control (BCC), which regulates distributors, retailers, delivery-only retailers, microbusinesses, temporary cannabis events and laboratories.

In November 2017, these three agencies released their emergency regulations and licensing requirements. They also announced a transition period during which cannabis businesses would be allowed to, in effect, disregard the new regulations. That transition period ended on June 30, 2018, commencing the new regulatory regime on July 1, 2018.

Now, among other restrictions, the following apply: untested cannabis goods cannot be sold by a retailer and must be destroyed, and those manufactured or harvested before January 1, 2018, in possession of a distributor that are owned by the distributor, will have to be destroyed. Moreover, all cannabis goods must be in child-resistant packaging; simply having child-resistant exit or secondary packaging is no longer enough. In addition, edible cannabis goods may no longer exceed 10 milligrams of THC per serving or 100 milligrams of THC per package, and non-edible cannabis products must not contain more than 1,000 milligrams of THC per package in the adult-use market (http://nnw.fm/712mA). Essentially, California is requiring shops to sell only marijuana that has been tested for pesticides, potency and microbiological contaminants.

The arrangement between Cannabis Strategic Ventures and Sunniva involves subsidiary companies (http://nnw.fm/8LnKU). Under it, CP Logistics, LLC (CPL), a wholly owned subsidiary of Sunniva, will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences, Inc. (PAS), Cannabis Strategic’s wholly owned subsidiary. The agreement calls for CPL to initially produce cannabis oils for use in PAS vape pen cartridges, which PAS will market under the Pure Organix™ brand, and expansion into other product areas is expected.

The new initiative will be given added impetus with the appointment of Chris Young, co-founder of PAS, to the board of directors of Cannabis Strategic Ventures (http://nnw.fm/38Cls). Young, who holds a JD from Southwestern Law and an MBA from the University of Southern California, has already built and exited two successful ventures. First, he founded a women’s fashion brand, which was sold two years later. Then, he co-founded Coordinates Collection, a luxury jewelry brand that’s marketed to over 500 stores in 10 countries. After his second successful exit, Young moved on to become a strategy and branding consultant developing consumer packaged goods (CPG) products for celebrity-led brands.